Explore Targeted Senolytics: A Higher Selectivity & Safety of Systemic Treatments for Geriatric Syndromes

Time: 11:45 am
day: Day Two


  • Examine novel small molecule designs for targeted, safe and systemic senolysis
  • Understand senolytic chronic treatments in geriatric preclinical models with high tolerability amelioration of frailty
  • Discuss improvement of age-dependent stem cell exhaustion and loss of regenerative potential recovery of age-related cognitive decline
  • Investigate platform to develop novel senolytic drugs to treat various age-related diseases